Annual accounts receivable:
N/ASummary
- SMMT annual accounts receivable is not available.
Performance
SMMT Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Quarterly accounts receivable:
N/ASummary
- SMMT quarterly accounts receivable is not available.
Performance
SMMT Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SMMT Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
SMMT Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
SMMT Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $349.00K(-76.2%) | $349.00K(+149.3%) |
| Sep 2022 | - | $140.00K(-41.2%) |
| Jun 2022 | - | $238.00K(-72.6%) |
| Mar 2022 | - | $870.00K(-40.6%) |
| Dec 2021 | $1.46M(+342.3%) | $1.46M(-36.1%) |
| Sep 2021 | - | $2.29M(+117.5%) |
| Jun 2021 | - | $1.05M(+135.6%) |
| Mar 2021 | - | $447.00K(+35.0%) |
| Dec 2020 | $331.00K(-38.8%) | - |
| Dec 2020 | - | $331.00K(-91.9%) |
| Sep 2020 | - | $4.08M(-66.3%) |
| Mar 2020 | - | $12.10M(+4.7%) |
| Dec 2019 | $541.00K(-75.1%) | - |
| Oct 2019 | - | $11.55M(-11.1%) |
| Jul 2019 | - | $12.99M(+497.9%) |
| Jan 2019 | $2.17M(-86.2%) | - |
| Jan 2019 | - | $2.17M(-86.2%) |
| Jan 2018 | $15.69M | - |
| Jan 2018 | - | $15.69M(+430.5%) |
| Apr 2015 | - | $2.96M(+38.0%) |
| Oct 2014 | - | $2.14M(-1.7%) |
| Jul 2014 | - | $2.18M(+438.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2013 | - | $405.40K(+403.0%) |
| Jan 2013 | $80.60K(+9.2%) | - |
| Jan 2013 | - | $80.60K(-70.7%) |
| Jul 2012 | - | $274.90K(+272.5%) |
| Jan 2012 | $73.80K(+45.8%) | - |
| Jan 2012 | - | $73.80K(-90.8%) |
| Jul 2011 | - | $805.80K(+1492.5%) |
| Jan 2011 | $50.60K(-22.7%) | - |
| Jan 2011 | - | $50.60K(-80.7%) |
| Jul 2010 | - | $262.20K(+300.3%) |
| Jan 2010 | $65.50K(-93.0%) | - |
| Jan 2010 | - | $65.50K(-87.6%) |
| Jul 2009 | - | $529.60K(-43.6%) |
| Jan 2009 | $938.30K(+149.7%) | - |
| Jan 2009 | - | $938.30K(-63.9%) |
| Jul 2008 | - | $2.60M(+592.3%) |
| Jan 2008 | $375.80K(-32.3%) | - |
| Jan 2008 | - | $375.80K(-90.0%) |
| Jul 2007 | - | $3.76M(+576.7%) |
| Jan 2007 | $555.10K(+141.0%) | - |
| Jan 2007 | - | $555.10K(+141.0%) |
| Jan 2006 | $230.30K(+205.8%) | - |
| Jan 2006 | - | $230.30K(-69.5%) |
| Jul 2005 | - | $754.40K(+901.9%) |
| Jan 2005 | $75.30K | - |
| Jan 2005 | - | $75.30K |
FAQ
- What is the all time high annual accounts receivable for Summit Therapeutics?
- What is the all time high quarterly accounts receivable for Summit Therapeutics?
What is the all time high annual accounts receivable for Summit Therapeutics?
Summit Therapeutics all-time high annual accounts receivable is $15.69M
What is the all time high quarterly accounts receivable for Summit Therapeutics?
Summit Therapeutics all-time high quarterly accounts receivable is $15.69M